chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Pretty much been a mess today with headache; Body aches; Chills; Fever; This spontaneous case was reported by an other and describes the occurrence of HEADACHE (Pretty much been a mess today with headache), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Pretty much been a mess today with headache), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, HEADACHE (Pretty much been a mess today with headache), MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            No concomitant medication was reported. No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Diarrhoea, Nasopharyngitis, Pyrexia
Clinical narrative: getting covid19; cold life symptoms; diarrhea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (getting covid19), NASOPHARYNGITIS (cold life symptoms), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN and LOVASTATIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced COVID-19 (getting covid19), NASOPHARYNGITIS (cold life symptoms), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, COVID-19 (getting covid19), NASOPHARYNGITIS (cold life symptoms), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Joint range of motion decreased, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of JOINT RANGE OF MOTION DECREASED (Could not lift arm up), ILLNESS (Illness), PYREXIA (Low grade fever), NAUSEA (Nausea) and MYALGIA (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA) from 24-Sep-2020 to an unknown date for Rheumatoid arthritis. On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT RANGE OF MOTION DECREASED (Could not lift arm up), ILLNESS (Illness), PYREXIA (Low grade fever), NAUSEA (Nausea), MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, JOINT RANGE OF MOTION DECREASED (Could not lift arm up), ILLNESS (Illness), PYREXIA (Low grade fever), NAUSEA (Nausea), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of JOINT RANGE OF MOTION DECREASED (Could not lift arm up), ILLNESS (Illness), PYREXIA (Low grade fever), NAUSEA (Nausea) and MYALGIA (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA) from 24-Sep-2020 to an unknown date for Rheumatoid arthritis. On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT RANGE OF MOTION DECREASED (Could not lift arm up), ILLNESS (Illness), PYREXIA (Low grade fever), NAUSEA (Nausea), MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, JOINT RANGE OF MOTION DECREASED (Could not lift arm up), ILLNESS (Illness), PYREXIA (Low grade fever), NAUSEA (Nausea), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Fatigue aggravated; Vaccination site pain; Headache recurrent; This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (Fatigue aggravated), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (Headache recurrent) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included Cyst ovary from April 2020 to September 2020, Appendicitis in January 2015, Elevated liver enzymes in 2017 and Shingles from November 2020 to December 2020. Concurrent medical conditions included General physical condition abnormal since 2012, Weight gain since 2012, Diabetes since 2016, Fatty liver and Psoriasis since 2016.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 27-Jan-2021, the patient experienced FATIGUE (Fatigue aggravated), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (Headache recurrent). On 30-Jan-2021, VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (Headache recurrent) had resolved. At the time of the report, FATIGUE (Fatigue aggravated) had resolved.            This case was linked to MOD-2021-047574 (Patient Link).   Reporter did not allow further contact
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose decreased, Feeling hot
Clinical narrative: blood sugar went down to 100 from 230; felt warm for 15 minutes; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (blood sugar went down to 100 from 230) and FEELING HOT (felt warm for 15 minutes) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BLOOD GLUCOSE DECREASED (blood sugar went down to 100 from 230) and FEELING HOT (felt warm for 15 minutes). On 16-Mar-2021, BLOOD GLUCOSE DECREASED (blood sugar went down to 100 from 230) had resolved. At the time of the report, FEELING HOT (felt warm for 15 minutes) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood glucose decreased: blood sugar went down to 100 from 230.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided. Action taken with mRNA-1273 in response to the event was unknown
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Mouth swelling, Paraesthesia, Pruritus
Clinical narrative: tingling all over body; itching; swelling of upper lip; partial swelling of roof of mouth; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling all over body), PRURITUS (itching), LIP SWELLING (swelling of upper lip) and MOUTH SWELLING (partial swelling of roof of mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PARAESTHESIA (tingling all over body), PRURITUS (itching), LIP SWELLING (swelling of upper lip) and MOUTH SWELLING (partial swelling of roof of mouth). At the time of the report, PARAESTHESIA (tingling all over body), PRURITUS (itching), LIP SWELLING (swelling of upper lip) and MOUTH SWELLING (partial swelling of roof of mouth) outcome was unknown.            Upon in internal review on 24 May 2021, the age was corrected to unknown age.  Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications were not reported.  Treatment information in response to events was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection site (left); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site (left)) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 07M20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site (left)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dose. On 17-Mar-2021, VACCINATION SITE PAIN (Pain at injection site (left)) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable. No Concomitant medication were reported.   This case was linked to MOD-2021-047694 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: contact updated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling, Somnolence, Tenderness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Drowsiness), VERTIGO (vertigo), TENDERNESS (Tenderness), ERYTHEMA (Red arm) and PERIPHERAL SWELLING (Swollen arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included HYDROCHLOROTHIAZIDE (HTZ), CITALOPRAM and VALACYCLOVIR [VALACICLOVIR] for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Drowsiness), VERTIGO (vertigo), TENDERNESS (Tenderness), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm) and PAIN (Achiness all over). The patient was treated with IBUPROFEN at an unspecified dose and frequency; Manual therapy (Icepack) for Tenderness; Manual therapy (Icepack) for Peripheral swelling and Manual therapy (Icepack) for Pain. At the time of the report, SOMNOLENCE (Drowsiness), VERTIGO (vertigo), TENDERNESS (Tenderness), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm) and PAIN (Achiness all over) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient experienced symptoms few days after vaccination.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Drowsiness), VERTIGO (vertigo), TENDERNESS (Tenderness), ERYTHEMA (Red arm) and PERIPHERAL SWELLING (Swollen arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included HYDROCHLOROTHIAZIDE (HTZ), CITALOPRAM and VALACYCLOVIR [VALACICLOVIR] for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Drowsiness), VERTIGO (vertigo), TENDERNESS (Tenderness), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm) and PAIN (Achiness all over). The patient was treated with IBUPROFEN at an unspecified dose and frequency; Manual therapy (Icepack) for Tenderness; Manual therapy (Icepack) for Peripheral swelling and Manual therapy (Icepack) for Pain. At the time of the report, SOMNOLENCE (Drowsiness), VERTIGO (vertigo), TENDERNESS (Tenderness), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm) and PAIN (Achiness all over) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient experienced symptoms few days after vaccination.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Vaccination site rash
Clinical narrative: SORE ARM; RASH ON ARM OF THE INJECTION SITE; RASH ON CHEST; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), VACCINATION SITE RASH (RASH ON ARM OF THE INJECTION SITE) and RASH (RASH ON CHEST) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE RASH (RASH ON ARM OF THE INJECTION SITE) and RASH (RASH ON CHEST). On an unknown date, the patient experienced PAIN IN EXTREMITY (SORE ARM). At the time of the report, PAIN IN EXTREMITY (SORE ARM), VACCINATION SITE RASH (RASH ON ARM OF THE INJECTION SITE) and RASH (RASH ON CHEST) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs were not reported. No treatment information was reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Pain in extremity, Pyrexia, Rash
Clinical narrative: Rash Post Second Dose (Neck, Chest and Under Breast); Fever 99.5F Post Second Dose; Chills Post Second Dose; Sore Left Arm Post Second Dose; Sore Left Armpit Post Second Dose; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm Post Second Dose), AXILLARY PAIN (Sore Left Armpit Post Second Dose), RASH (Rash Post Second Dose (Neck, Chest and Under Breast)), PYREXIA (Fever 99.5F Post Second Dose) and CHILLS (Chills Post Second Dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm Post Second Dose), AXILLARY PAIN (Sore Left Armpit Post Second Dose), PYREXIA (Fever 99.5F Post Second Dose) and CHILLS (Chills Post Second Dose). On 05-Feb-2021, the patient experienced RASH (Rash Post Second Dose (Neck, Chest and Under Breast)). At the time of the report, PAIN IN EXTREMITY (Sore Left Arm Post Second Dose), AXILLARY PAIN (Sore Left Armpit Post Second Dose), RASH (Rash Post Second Dose (Neck, Chest and Under Breast)), PYREXIA (Fever 99.5F Post Second Dose) and CHILLS (Chills Post Second Dose) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-021396 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Rash, Skin burning sensation
Clinical narrative: skin got so dry and looks like burn; skin got so dry and looks like burn; broke out with rash on face, cheeks and neck; This spontaneous case was reported by a consumer and describes the occurrence of RASH (broke out with rash on face, cheeks and neck), DRY SKIN (skin got so dry and looks like burn) and SKIN BURNING SENSATION (skin got so dry and looks like burn) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced RASH (broke out with rash on face, cheeks and neck). On an unknown date, the patient experienced DRY SKIN (skin got so dry and looks like burn) and SKIN BURNING SENSATION (skin got so dry and looks like burn). At the time of the report, RASH (broke out with rash on face, cheeks and neck), DRY SKIN (skin got so dry and looks like burn) and SKIN BURNING SENSATION (skin got so dry and looks like burn) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Heart rate, Nervousness
Clinical narrative: jittery; WEAKNESS; Feels very tired; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (jittery), ASTHENIA (WEAKNESS) and FATIGUE (Feels very tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac). Concurrent medical conditions included Brugada syndrome. Concomitant products included QUINIDINE, METOPROLOL, BUPROPION HYDROCHLORIDE (WELLBUTRIN) and VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced NERVOUSNESS (jittery), ASTHENIA (WEAKNESS) and FATIGUE (Feels very tired). At the time of the report, NERVOUSNESS (jittery), ASTHENIA (WEAKNESS) and FATIGUE (Feels very tired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Heart rate: fast (High) Fast.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Pain in extremity
Clinical narrative: Right arm hurting from shoulder to elbow; Burning sensation on the left arm; Shoulder pain on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm hurting from shoulder to elbow), BURNING SENSATION (Burning sensation on the left arm) and ARTHRALGIA (Shoulder pain on the left arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm hurting from shoulder to elbow), BURNING SENSATION (Burning sensation on the left arm) and ARTHRALGIA (Shoulder pain on the left arm). At the time of the report, PAIN IN EXTREMITY (Right arm hurting from shoulder to elbow), BURNING SENSATION (Burning sensation on the left arm) and ARTHRALGIA (Shoulder pain on the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-1901, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Vaccination site erythema
Clinical narrative: Barely can lift my arm; Red around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTED LIMB MOBILITY DECREASED (Barely can lift my arm) and VACCINATION SITE ERYTHEMA (Red around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (Barely can lift my arm) and VACCINATION SITE ERYTHEMA (Red around the injection site). At the time of the report, INJECTED LIMB MOBILITY DECREASED (Barely can lift my arm) and VACCINATION SITE ERYTHEMA (Red around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 86.0
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: shorth of breath; feeling woozy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shorth of breath) and DIZZINESS (feeling woozy) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DYSPNOEA (shorth of breath) and DIZZINESS (feeling woozy). At the time of the report, DYSPNOEA (shorth of breath) and DIZZINESS (feeling woozy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: sore; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (sore) and FATIGUE (tired). At the time of the report, PAIN (sore) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Pyrexia, SARS-CoV-2 test
Clinical narrative: tested positive for COVID-19; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19), PYREXIA (Fever) and CHILLS (Chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 01-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19). The patient was treated with IBUPROFEN for Fever and Chills, at an unspecified dose and frequency; VITAMIN D NOS for Fever and Chills, at an unspecified dose and frequency and ZINC for COVID-19, at an unspecified dose and frequency. On 10-Mar-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, COVID-19 (tested positive for COVID-19) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, SARS-CoV-2 test: unknown (Positive) positive. On 15-Mar-2021, SARS-CoV-2 test: unknown (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Antibiotics were also reported to be given for treatment of COVID-19.
Sex: M
Vaccine: COVID19
Symptoms: Energy increased, Pain in extremity, Therapeutic response unexpected
Clinical narrative: feels like my testosterone is high, feel younger.; mild sore arm; now the joint pain is gone after taking the first dose; This spontaneous case was reported by a consumer and describes the occurrence of ENERGY INCREASED (feels like my testosterone is high, feel younger.), PAIN IN EXTREMITY (mild sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (now the joint pain is gone after taking the first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Joint pain. Concomitant products included ALPRAZOLAM (XANAX) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ENERGY INCREASED (feels like my testosterone is high, feel younger.), PAIN IN EXTREMITY (mild sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (now the joint pain is gone after taking the first dose). At the time of the report, ENERGY INCREASED (feels like my testosterone is high, feel younger.) and THERAPEUTIC RESPONSE UNEXPECTED (now the joint pain is gone after taking the first dose) outcome was unknown and PAIN IN EXTREMITY (mild sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Site of injection feels warm; Site of injection is itchy; Site of injection is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Site of injection feels warm), VACCINATION SITE PRURITUS (Site of injection is itchy) and VACCINATION SITE ERYTHEMA (Site of injection is red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Site of injection feels warm), VACCINATION SITE PRURITUS (Site of injection is itchy) and VACCINATION SITE ERYTHEMA (Site of injection is red). At the time of the report, VACCINATION SITE WARMTH (Site of injection feels warm), VACCINATION SITE PRURITUS (Site of injection is itchy) and VACCINATION SITE ERYTHEMA (Site of injection is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Tinnitus, Vertigo, Vestibular migraine
Clinical narrative: Vestibular migraine; Tinnitus; llness in ear; Mild vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VESTIBULAR MIGRAINE (Vestibular migraine), TINNITUS (Tinnitus), EAR DISCOMFORT (llness in ear) and VERTIGO (Mild vertigo) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032LZ0A) for COVID-19 vaccination.     The patient's past medical history included Meniere's disease (flare up on or around 01-MAR-2021) in 2006.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VESTIBULAR MIGRAINE (Vestibular migraine), TINNITUS (Tinnitus) and EAR DISCOMFORT (llness in ear). 01-Mar-2021, the patient experienced VERTIGO (Mild vertigo). At the time of the report, VESTIBULAR MIGRAINE (Vestibular migraine), TINNITUS (Tinnitus), EAR DISCOMFORT (llness in ear) and VERTIGO (Mild vertigo) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Ocular discomfort, Pyrexia
Clinical narrative: headache on one side of her face; heavy pressure over the right eye; her vision is blurry; dizziness; feeling tired; fever; A spontaneous report  was received from a other hcp concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache on one side of her face, heavy pressure over the right eye, her vision is blurry.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 16 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 047A21A) via unknown route for prophylaxis of COVID-19 infection.  On 16 Mar 2021, the patient experienced the event(s) headache on one side of her face, heavy pressure over the right eye, her vision is blurry.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), headache on one side of her face, heavy pressure over the right eye, her vision is blurry was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: headache on one side of her face; heavy pressure over the right eye; her vision is blurry; dizziness; feeling tired; fever; A spontaneous report  was received from a other hcp concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache on one side of her face, heavy pressure over the right eye, her vision is blurry.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 16 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 047A21A) via unknown route for prophylaxis of COVID-19 infection.  On 16 Mar 2021, the patient experienced the event(s) headache on one side of her face, heavy pressure over the right eye, her vision is blurry.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), headache on one side of her face, heavy pressure over the right eye, her vision is blurry was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Pyrexia, Tremor
Clinical narrative: memory loss; bad tremors; fever; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (memory loss), TREMOR (bad tremors) and PYREXIA (fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced AMNESIA (memory loss), TREMOR (bad tremors) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, AMNESIA (memory loss), TREMOR (bad tremors) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity
Clinical narrative: two painful events in foot; second painful event in foot was not as severe as the first episode; hand pain with a clot on the inside of wrist with spontaneous bruising; one painful event in hand; spontaneous pain and bruising on the left foot above the heal which prevented the patient from; A spontaneous report was received from a consumer concerning a 45-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events two painful in foot, one painful event in hand, spontaneous pain and bruising on the left foot above the heal which prevented the patient from, second painful event in foot was not as severe as the first episode, hand pain with a clot on the inside of wrist with spontaneous bruising.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) two painful in foot. On 16 Mar 2021, the patient experienced the event(s) one painful event in hand. On 10 Mar 2021, the patient experienced the event(s) spontaneous pain and bruising on the left foot above the heal which prevented the patient from, second painful event in foot was not as severe as the first episode, hand pain with a clot on the inside of wrist with spontaneous bruising.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), two painful in foot, one painful event in hand, spontaneous pain and bruising on the left foot above the heal which prevented the patient from, second painful event in foot was not as severe as the first episode, hand pain with a clot on the inside of wrist with spontaneous bruising was unknown.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Diagnosed with COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID-19) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0401L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID-19). At the time of the report, COVID-19 (Diagnosed with COVID-19) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. Treatment include Steroids and Antibiotics
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: chills; fever; arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever) and PAIN IN EXTREMITY (arm hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included No adverse event (No medical history reported).   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and PAIN IN EXTREMITY (arm hurts). At the time of the report, CHILLS (chills), PYREXIA (fever) and PAIN IN EXTREMITY (arm hurts) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided Treatment not provided
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (late second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (late second dose). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (late second dose) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Intentional dose omission, SARS-CoV-2 test
Clinical narrative: Patient hasn't received her 2nd dose yet; Patient was positive for covid 5 days after receiving 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Patient was positive for covid 5 days after receiving 1st dose) and INTENTIONAL DOSE OMISSION (Patient hasn't received her 2nd dose yet) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR) for an unknown indication.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced COVID-19 (Patient was positive for covid 5 days after receiving 1st dose). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (Patient hasn't received her 2nd dose yet). At the time of the report, COVID-19 (Patient was positive for covid 5 days after receiving 1st dose) outcome was unknown and INTENTIONAL DOSE OMISSION (Patient hasn't received her 2nd dose yet) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Ultrasound scan
Clinical narrative: Exposure to Pregnancy; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Exposure to Pregnancy) in a 28-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 037A21B) for COVID-19 vaccination.     The patient's past medical history included Miscarriage in October 2020. Concurrent medical conditions included Penicillin allergy, Drug allergy (Sulfur based medicines), Depression since January 2013, Anxiety since January 2013 and Exercise induced asthma since January 2005. Concomitant products included SERTRALINE for Depression, DOXYLAMINE SUCCINATE (UNISOM 2) for Nausea, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. The patient's last menstrual period was on 02-Feb-2021 and the estimated date of delivery was 07-Nov-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Exposure to Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Exposure to Pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Ultrasound scan: baby heart rate 163 Baby heart rate of 163 measuring 7wld.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken were pre natal vitamins, Sertraline, Unisom. No Treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Pregnancy case, no AE On 21-Jun-2021: Pregnancy update, no new info added
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm soreness at injection site after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm soreness at injection site after first dose) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness at injection site after first dose). At the time of the report, VACCINATION SITE PAIN (Arm soreness at injection site after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives to upper body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives to upper body) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced URTICARIA (Hives to upper body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of Pills and HYDROCORTISONE at an unspecified dose and frequency. On 10-Mar-2021, URTICARIA (Hives to upper body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dizziness, Erythema, Pruritus
Clinical narrative: heart showed calcification; light headedness; Itching; Redness; Bothers Ear rings a lot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), ERYTHEMA (Redness), DISCOMFORT (Bothers Ear rings a lot), ARTERIOSCLEROSIS CORONARY ARTERY (heart showed calcification) and DIZZINESS (light headedness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 04-Mar-2021, the patient experienced PRURITUS (Itching), ERYTHEMA (Redness), DISCOMFORT (Bothers Ear rings a lot) and DIZZINESS (light headedness). On an unknown date, the patient experienced ARTERIOSCLEROSIS CORONARY ARTERY (heart showed calcification). At the time of the report, PRURITUS (Itching), ERYTHEMA (Redness), DISCOMFORT (Bothers Ear rings a lot), ARTERIOSCLEROSIS CORONARY ARTERY (heart showed calcification) and DIZZINESS (light headedness) outcome was unknown.            Concomitant medication was not provided by the reporter. Treatment details included Applied scented oil on the arm.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Feeling abnormal
Clinical narrative: brain fog; shortness of breath; feeling weak; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain fog), DYSPNOEA (shortness of breath) and ASTHENIA (feeling weak) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced FEELING ABNORMAL (brain fog), DYSPNOEA (shortness of breath) and ASTHENIA (feeling weak). At the time of the report, FEELING ABNORMAL (brain fog), DYSPNOEA (shortness of breath) and ASTHENIA (feeling weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.